Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 2 (2007), Issue 1 (January)

1. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.
   J Clin Gastroenterol, 41(1): 111-4. [Abstract] [Full-text]
2. Hepatitis C in HIV-positive patients--treatment and liver disease outcomes.
   J Clin Gastroenterol, 41(1): 75-87. [Abstract] [Full-text]
3. Should antihepatitis B virus core positive or antihepatitis C virus core positive subjects be accepted as organ donors for liver transplantation?
   J Clin Gastroenterol, 41(1): 66-74. [Abstract] [Full-text]
4. Retinal circulatory changes associated with interferon-induced retinopathy in patients with hepatitis C.
   Invest Ophthalmol Vis Sci, 48(1): 368-75. [Abstract] [Full-text]
5. The restorative effect of taurine on experimental nonalcoholic steatohepatitis.
   Dig Dis Sci, 51(12): 2225-34. [Abstract] [Full-text]
6. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
   Pediatrics, 119(1): e22-9. [Abstract] [Full-text]
7. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
   Pediatrics, 119(1): e12-21. [Abstract] [Full-text]
8. Immunopathogenesis in hepatitis C virus cirrhosis.
   Clin Sci (Lond), 112(3): 141-55. [Abstract] [Full-text]
9. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
   J Gastroenterol Hepatol, 22(1): 92-8. [Abstract] [Full-text]
10. Multiple viral hepatitis in injection drug users and associated risk factors.
    J Gastroenterol Hepatol, 22(1): 80-5. [Abstract] [Full-text]
11. Immune response in addicts with chronic hepatitis C treated with interferon and ribavirin.
    J Gastroenterol Hepatol, 22(1): 74-9. [Abstract] [Full-text]
12. Analysis of differential gene expression between chronic hepatitis B patients and asymptomatic hepatitis B carriers.
    J Gastroenterol Hepatol, 22(1): 68-73. [Abstract] [Full-text]
13. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.
    Epilepsia, 47(12): 2027-31. [Abstract] [Full-text]
14. HepSEQ: International Public Health Repository for Hepatitis B.
    Nucleic Acids Res, 35: D367-70. [Abstract] [Full-text]
15. Evaluation of alpha-glutathione-S-transferase as a biomarker of lamivudine therapy for chronic hepatitis B.
    Dig Dis Sci, 51(10): 1706-11. [Abstract] [Full-text]
16. The effects of light and moderate-heavy ethanol exposure on the development of cirrhosis in rats.
    Dig Dis Sci, 51(10): 1732-7. [Abstract] [Full-text]
17. The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
    J Infect Dis, 195(3): 432-41. [Abstract] [Full-text]
18. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
    Clin Infect Dis, 44(3): e17-24. [Abstract] [Full-text]
19. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
    J Pediatr Gastroenterol Nutr, 44(1): 92-8. [Abstract] [Full-text]
20. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.
    J Pediatr Gastroenterol Nutr, 44(1): 84-91. [Abstract] [Full-text]
21. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Transfusion, 47(1): 74-9. [Abstract] [Full-text]
22. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
    Free Radic Biol Med, 42(3): 353-62. [Abstract] [Full-text]
23. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
    AIDS Res Hum Retroviruses, 22(12): 1236-41. [Abstract] [Full-text]
24. Survey of HIV and hepatitis B or C co-infection management in the UK 2004.
    Int J STD AIDS, 17(12): 799-801. [Abstract] [Full-text]
25. Detection and quantification of hepatitis B virus DNA by SYBR green real-time polymerase chain reaction.
    Eur J Clin Microbiol Infect Dis, 26(1): 43-50. [Abstract] [Full-text]
26. Hepatitis viruses in non-human primates.
    J Med Primatol, 35(6): 384-7. [Abstract] [Full-text]
27. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States.
    Dig Dis Sci, 52(1): 220-7. [Abstract] [Full-text]
28. Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytes.
    Toxicol Lett, 168(2): 140-7. [Abstract] [Full-text]
29. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B.
    Clin Immunol, 122(2): 173-80. [Abstract] [Full-text]
30. Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1.
    Virus Res, 123(2): 161-9. [Abstract] [Full-text]
31. Unusual cardiac features in cholestatic hepatitis A in an adolescent: improvement with corticosteroid treatment.
    J Infect, 54(2): e91-3. [Abstract] [Full-text]
32. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients.
    J Infect, 54(2): 173-9. [Abstract] [Full-text]
33. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea.
    J Infect, 54(2): 185-91. [Abstract] [Full-text]
34. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.
    Am J Transplant, 7(1): 195-200. [Abstract] [Full-text]
35. Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C.
    Am J Gastroenterol, 101(12): 2744-51. [Abstract] [Full-text]
36. The emerging importance of chronic hepatitis C infection in Asian Americans.
    Am J Gastroenterol, 101(12): 2737-43. [Abstract] [Full-text]
37. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis.
    Am J Gastroenterol, 101(12): 2731-6. [Abstract] [Full-text]
38. A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection.
    Proc Natl Acad Sci U S A, 104(3): 985-90. [Abstract] [Full-text]
39. Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C.
    Dig Dis Sci, 52(1): 179-84. [Abstract] [Full-text]
40. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients.
    Am J Gastroenterol, 101(12): 2752-9. [Abstract] [Full-text]
41. Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient sera.
    Antiviral Res, 73(1): 40-9. [Abstract] [Full-text]
42. Risk of hepatitis B virus transmission via dental handpieces and evaluation of an anti-suction device for prevention of transmission.
    Infect Control Hosp Epidemiol, 28(1): 80-2. [Abstract] [Full-text]
43. Prevalence and risk factors for bloodborne exposure and infection in correctional healthcare workers.
    Infect Control Hosp Epidemiol, 28(1): 24-30. [Abstract] [Full-text]
44. Inflammation, damage repair and liver fibrosis--role of cytokines and different cell types.
    Z Gastroenterol, 45(1): 77-86. [Abstract] [Full-text]
45. Steroid treatment for severe acute cryptogenic hepatitis.
    Z Gastroenterol, 45(1): 15-9. [Abstract] [Full-text]
46. Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users.
    Drug Alcohol Depend, 85(3): 236-43. [Abstract] [Full-text]
47. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    J Thromb Haemost, 5(1): 25-30. [Abstract] [Full-text]
48. Clinical spectrum and histopathologic features of chronic hepatitis C infection in children.
    J Pediatr, 150(2): 168-74, 174.e1. [Abstract] [Full-text]
49. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
    Vaccine, 25(9): 1662-8. [Abstract] [Full-text]
50. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Clin Infect Dis, 44(4): 584-90. [Abstract] [Full-text]
51. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection.
    Clin Infect Dis, 44(4): 577-83. [Abstract] [Full-text]
52. Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.
    Clin Infect Dis, 44(4): 541-8. [Abstract] [Full-text]
53. Changing patterns of acute viral hepatitis at a major urban referral center in Egypt.
    Clin Infect Dis, 44(4): e30-6. [Abstract] [Full-text]
54. Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity.
    Gastroenterology, 132(1): 372-83. [Abstract] [Full-text]
55. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis.
    Gastroenterology, 132(1): 343-57. [Abstract] [Full-text]
56. A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication.
    Gastroenterology, 132(1): 311-20. [Abstract] [Full-text]
57. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
    Gastroenterology, 132(1): 272-81. [Abstract] [Full-text]
58. Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
    Gastroenterology, 132(1): 103-12. [Abstract] [Full-text]
59. Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
    Toxicology, 230(2): 197-206. [Abstract] [Full-text]
60. Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.
    J Clin Gastroenterol, 41(2): 216-20. [Abstract] [Full-text]
61. Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?
    J Clin Gastroenterol, 41(2): 199-205. [Abstract] [Full-text]
62. Hepatitis C in African Americans.
    J Clin Gastroenterol, 41(2): 185-93. [Abstract] [Full-text]
63. Declining trend in the seroprevalence of infection with hepatitis A virus in Thailand.
    Ann Trop Med Parasitol, 101(1): 61-8. [Abstract] [Full-text]
64. Molecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriers.
    Virol J, 4: 6. [Abstract] [Full-text]
65. Efficacy of Sargassum polycystum (Phaeophyceae) sulphated polysaccharide against paracetamol-induced DNA fragmentation and modulation of membrane-bound phosphatases during toxic hepatitis.
    Clin Exp Pharmacol Physiol, 34(3): 142-7. [Abstract] [Full-text]
66. Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis.
    Alcohol Clin Exp Res, 31(2): 285-92. [Abstract] [Full-text]
67. Hepatitis B "by proxy": an emerging presentation of chronic hepatitis B in children.
    J Pediatr Gastroenterol Nutr, 44(2): 268-9. [Abstract] [Full-text]
68. Improving the treatment of hepatitis C infection in the UK.
    Expert Opin Pharmacother, 8(2): 183-91. [Abstract] [Full-text]
69. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
    Transplantation, 83(2): 231-3. [Abstract] [Full-text]
70. Academic health center management of chronic diseases through knowledge networks: Project ECHO.
    Acad Med, 82(2): 154-60. [Abstract] [Full-text]
71. Can current national surveillance systems in England and Wales monitor sexual transmission of hepatitis C among HIV-infected men who have sex with men?
    BMC Public Health, 7: 7. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.